KIT p.Asp816fs
c.2446_2447del · rs2475571995 · VCV2770878
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | frameshift | predicted loss-of-function in a haploinsufficient gene (ClinGen) |
|---|---|---|
| NMD | predicted | premature termination codon in exon 17 of 21 |
| Splicing | ||
| SpliceAI | — | not assessed · substitutions only |
| Constraint at this position | ||
| Conservation | phyloP 2.2 | GERP 0.77, phastCons 1 |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
No gnomAD frequency available for this variant. This is missing data, not an absence: the variant may or may not be present in gnomAD. Rarity (ACMG PM2) and BA1/BS1 cannot be assessed for it.
Variant & gene context
- Gene
- KIT
- Protein
- p.Asp816fs
- Coding
- c.2446_2447del
- MANE Select
- NM_000222
- dbSNP
- rs2475571995
- Type
- Microsatellite
- Location
- chr4:54733151 (GRCh38)
- Gene constraint
- LOEUF 0.24 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 78.52 · 65 PDB
- Residue 816
- the protein kinase domain; a UniProt-annotated variant site (in mastc; sporadic case; somatic mutation; constitutively activated and is much more rapidly autophosphorylated than wild type; requires 2 nucleotide substitutions); a UniProt-annotated variant site (in a testicular tumor; seminoma; somatic mutation; constitutively activated); a UniProt-annotated variant site (in mastc; somatic mutation; constitutively activated; requires 2 nucleotide substitutions); a UniProt-annotated variant site (in mastsys, mastc and mast cell leukemia; somatic mutation; constitutively activated; loss of interaction with mpdz); a UniProt-annotated variant site (in mastsys and mastc; also found in acute myeloid leukemia and a germ cell tumor of the testis; somatic mutation; constitutively activated)
Disease context
gastrointestinal stromal tumor — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Gastrointestinal stromal tumor (Orphanet):
- Inheritance
- Autosomal dominant, Not applicable
- Onset
- Adolescent, Adult, Childhood
- Prevalence
- 1-5 / 10 000 (Europe)
Similar variants
- KIT p.Asp816Asn Uncertain significance ★★ ⚠ same residue
- KIT p.Asp816= Conflicting classifications of pathogenicity ★ same residue
- KIT p.Asp816Gly Uncertain significance ★ ⚠ same residue
- KIT p.Asp816Tyr Uncertain significance ★ ⚠ same residue
- KIT p.Asp816Val Conflicting classifications of pathogenicity ★ ⚠ same residue
- KIT p.Asp816His Pathogenic ★★ same residue
- KIT p.Glu562del Uncertain significance ★★ same condition
- KIT c.2597-7_2597-6del Likely benign ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/kit-p-asp816fs (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown